期刊文献+

艾司西酞普兰与帕罗西汀治疗抑郁症的对照研究 被引量:2

Comparative study between escitalopram and paroxetine in the treatment of depression
下载PDF
导出
摘要 目的:观察艾司西酞普兰与帕罗西汀治疗抑郁症的疗效及安全性。方法:将58例抑郁症患者随机分为艾司西酞普兰组和帕罗西汀组,疗程6周。采用汉密尔顿抑郁量表(HAMD),及治疗中出现的症状用量表(TESS)评定疗效和不良反应。结果:艾司西酞普兰组与帕罗西汀组显效率分别为82.7%和75.9%。两组疗效相仿。但治疗1周后,艾司西酞普兰组的有效率高于帕罗西汀组。结论:艾司西酞普兰是一种安全有效的抗抑郁药。 Objective:To observe the clinical efficacy and safety between escitalporam and paroxetine in the treatment of depression. Methods :58 patients with depression were randomly devided into escitalopram group and paroxetine group for 6 weeks. Hamilton rating scale for depression (HAMD) and treatment emergent symptoms scales(TESS) were used to evaluate the efficacy and adverse effects. Results: The effective rate of escitalopram was 82.7% and paroxetine group was75.9%. Escitalopram group showed a higher response rate compared with paroxetine group after one week treatment. Conclusions: Escitalopram is an effective and safe drug in the treatment of depression.
作者 王维扬
机构地区 江苏省荣军医院
出处 《中国民康医学》 2009年第11期1291-1291,1301,共2页 Medical Journal of Chinese People’s Health
关键词 艾司西酞普兰 帕罗西汀 抑郁症 Escitalopram Paroxetine Depression
  • 相关文献

参考文献3

  • 1乔颖,黄继忠.艾司西酞普兰治疗抑郁症临床疗效研究进展[J].国际精神病学杂志,2008,35(3):179-182. 被引量:23
  • 2Baldwin DS,Cooper JA,Huusom A.A double-blind,randomized,parallel-group,flexible-dose study to evaluate the tolerability,efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder.International Clinical Psychopharmacology,2006,21:159-169.
  • 3Lepola UM,Loft H,Reines EH.Escitalopram(10-20mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.International Clinical Psychopharmacology,2003,18:211-217.

二级参考文献15

  • 1Murdoch D, Keam SJ. Escitalopram: a review of its use in the management of major depressive disorder. Drugs, 2005; 65 (16) : 2379-2404.
  • 2Khan MNS. Comparison of escitalopram with clomipramine in major depressive disorder: a double blind study. Pakistan Journal Medical Science, 2004; 20 (3): 238-241.
  • 3Moore N, Verdoux H, Fantino B. Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder. International Clinical Psychopharmacology, 2005; 20: 131-137.
  • 4Lepola UM, Loft H, Reines EH. Escitalopram (10 - 20mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. International Clinical Psychopharmacology, 2003; 18: 211-217.
  • 5Baldwin DS, Cooper JA, Huusom A. A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder. International Clinical Psychopharmacology, 2006; 21:159-169.
  • 6Montgomery SA, Anderson HF. Escitalopram versus venlafaxine XR in the treatment of depression. International Clinical Psychopharmacology, 2006; 21: 297-309.
  • 7Bielski RI, Ventura D, Chang CC. A double-blind comparison of esciaflopram and venlafaxine XR in the treatment of major depressive disorder. Journal of Clinical Psychiatry, 2004; 65: 1190-1196.
  • 8Kennedy SH, Anderson HF, Lam RW. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional SSRIs and venlafaxine XR: a meta-analysis. Journal of Psychiatry Neuroscience, 2006; 31 (2): 122-131.
  • 9Khan A, Bose A, Alexopoulos GS, et al. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder. Clinical Drug Invest. 2007 ; 27 (7) : 481-492.
  • 10Clayton AH, Croft HA, Horrigan JP, et al. Bupropion XR compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebocontrolled studies. Journal of Clinical Psychiatry, 2006; 67: 736-746.

共引文献22

同被引文献23

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部